Blueprint Medicines shares owned by UBS O'Connor
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.1M | 22k | 92.50 |
| 2024-03-31 | $1.7M | 18k | 94.86 |
| 2023-09-30 | $142k | 74k | 1.92 |
| 2023-06-30 | $3.0M | 48k | 63.20 |
| 2023-03-31 | $2.2M | 49k | 44.99 |
| 2022-12-31 | $1.8M | 42k | 43.82 |
| 2022-06-30 | $1.0M | 20k | 50.52 |
| 2022-03-31 | $1.0M | 16k | 63.88 |